
Cannabidiol (CBD), one of 113 cannabinoids in cannabis plants, could be used to deliver medicines into the brain, according to …

The multiple sclerosis drug ibudilast, slowed brain shrinkages in patients with progressive MS, a study published in the New England …

Researchers from Northwestern Medicine and the Rehabilitation Institute of Chicago (RIC) have pinpointed, for the first time, exactly which region …
A US biotech firm has announced plans for a Phase I trial that will see them attempt to bring brain-dead …

The Medical Research Council (MRC) has launched the UK Dementias Research Platform (UKDP), a £16 million public-private partnership set up …

Cancer Research UK is to increase its research funding by 50% over the next decade as part of a new strategy …
Lundbeck has entered into a new partnership with the Lieber Institute for Brain Development in the hope of discovering new …

Neurological rehabilitation firm Glenside are running a large-scale pilot which uses smartphone technology to improve the lives of people with …

Researchers have developed a cranial implant that could act as a brain ‘window’, making life-changing procedures safer and easier. The …

A new study has found that the rate of dementia in Britain has decreased over the past two decades, contrary …

Eli Lilly’s diagnostic radiopharmaceutical Amyvid has been approved in Europe to assess whether patients have Alzheimer’s disease. Amyvid (Florbetapir F …

In a Phase III trial, Roche’s Avastin has helped people with newly-diagnosed glioblastoma (GBM) live longer without their disease worsening. …